Virilizing ovarian tumors in postmenopause: a literature review and a rare clinical case
Background. Sertoli–Leydig cell ovarian tumors are rare and account for less than 0.5% of all ovarian tumors. Sertoli–Leydig cell tumors can develop in women of any age group; however, they are more common in young female patients with a mean age of 25 years. The distinguishing feature of Sertoli–Leydig cell tumors is their ability to secrete androgens that may cause defeminization. It is rather difficult to diagnose androgen-producing tumors in postmenopause, since the sharp decline in estrogen levels and a slower decrease in androgen levels while maintaining the synthesis throughout life are natural hormonal changes.Ponomareva Yu.N., Loginova E.A., Telezhnikova I.M.
Case report. The paper analyzes literature data and a rare clinical case of Sertoli–Leydig cell tumor in postmenopausal female patient with breast cancer. The patient was observed to have pronounced signs of virilism: hirsutism, deepening voice, alopecia, and clitoromegaly. MRI revealed a 33-mm left solid ovarian tumor accumulating a contrast agent. She was diagnosed with an increase in blood testosterone levels up to 10 nmol/L (normal value, less than 1.24 nmol/L). The patient underwent surgical treatment: laparoscopy, hysterectomy, bilateral removal of the appendages, and omentectomy. Morphological examination diagnosed a moderate left Sertoli–Leydig cell ovarian tumor. The testosterone level was noted to decrease after surgery. No tumor recurred during one year of follow-up.
Conclusion. Thus, postmenopausal patients with pronounced signs of hyperandrogenism should be examined to exclude rare diseases, such as androgen-producing tumors.
Keywords
Sertoli–Leydig cell tumor
sex cord tumor
postmenopause
defeminization
virilization
androgen-producing tumors
hysterectomy
References
- Tandon R., Goel P., Saha P.K., Takkar N., Punia R.P. A rare ovarian tumor – Sertoli–Leydig cell tumor with heterologous element. MedGenMed. 2007; 9(4): 44.
- Chakrabarti I., De A., Gangopadhyay M., Bera P. Sertoli–Leydig cell tumour of ovary with heterologous elements – a case report. Internet J. Gynecol. Obstet. 2010; 13(1): 1-4.
- Ray-Coquard I. Ovarian tumors of sex cord-stromal origin. Orphanet Encyclopedia. 2004: 1-4. Available at: http://www.orpha.net/data/patho/GB/uk-STROMA.pdf
- Vaishali D.R., Kalpana D.S., Meeta M.H. Sertoli–Leydig cell tumors of ovary. J. Obstet. Gynecol. (India). 2009; 59(2): 165-7.
- Monappa V., Reddy S.M., Kudva R., Pai M.V. Cystic Sertoli–Leydig cell tumour in a postmenopausal woman with absent virilising symptoms: a diagnostic challenge. J. Clin. Diagn. Res. 2017; 11(5): ED26-8. https://dx.doi.org/ 10.7860/JCDR/2017/26173.9901.
- Roth L.M., Anderson M.C., Govan A.D.T., Langley F.A., Gowing N.F.C., Woodcock A.S. Sertoli–Leydig cell tumour: a clinicopathologic study of 34 cases. Cancer. 1981; 48(1): 187-97. https://dx.doi.org/10.1002/1097-0142(19810701)48:1<187::aid-cncr2820480130>3.0.co;2-1.
- Olt G., Mortel R. Hormone-producing tumors of the ovary. Endocrine-Related Cancer. 1997; 4(4): 447-57. https://dx.doi.org/10.1677/erc.0.0404447.
- Черепанова Е.В., Лактионов К.П., Анурова О.А., Толокнов Б.О., Зотиков А.И. Клинико-морфологические особенности опухолей яичников из клеток Сертоли–Лейдига. Опухоли женской репродуктивной системы. 2010; 4: 83-9. [Cherepanova E.V., Laktionov K.P., Anurova O.A., Toloknov B.O., Zotikov A.I. Clinical and morphological features of ovarian tumors from Sertoli–Leydig cells. Tumors of the female reproductive system. 2010; 4: 83-9.(in Russian)].
- Gouy S., Arfi A., Maulard A., Pautier P., Bentivegna E., Leary A. et al. Results from a monocentric long-term analysis of 23 patients with ovarian Sertoli–Leydig cell tumors. Oncologist. 2019; 24(5): 702-9. https://dx.doi.org/10.1634/theoncologist.2017-0632.
- Omeroglu A., Husain A.N., Siziopikou K. Pathologic quiz case: a papillary ovarian tumor in a 4-year-old girl. Arch. Pathol. Lab. Med. 2002; 126(3): 377-8. https://dx.doi.org/10.1043/0003-9985(2002)126<0377:PQCAPO>2.0.CO;2.
- Chen M., Zhou W., Zhang Z., Zou Y., Li C. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: a case report. Medicine (Baltimore). 2018; 97(10): e0093. https://dx.doi.org/10.1097/MD.0000000000010093.
- Young R.H. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod. Pathol. 2005; 18(Suppl. 2): S81-98. https://dx.doi.org/10.1038/modpathol.3800311.
- Adashi E.Y. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil. Steril. 1994; 62(1): 20-7.https://dx.doi.org/10.1016/s0015-0282(16)56810-1.
- Seidman J.D., Patterson J.A., Bitterman P. Sertoli–Leydig cell tumor associated with a mature cystic teratoma in a single ovary. Mod. Pathol. 1989; 2(6): 687-92.
- Gautam P., Rao M., Gothwal M., Garg P.K., Bhattacharya S. Sertoli–Leydig cell tumor of ovary: a rare case report with heterologous elements and focal marked anaplasia. Int. J. Appl. Basic Med. Res. 2019; 9(1): 62-4. https://dx.doi.org/10.4103/ijabmr.IJABMR_84_18.
- Burnik Papler T., Frković Grazio S., Kobal B. Sertoli–Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review. J. Ovarian Res. 2016; 9(1): 46. https://dx.doi.org/10.1186/s13048-016-0257-4.
- Sherf S., Martinez D. Leydig cell tumor in the post-menopausal woman: case report and literature review. Acta Biomed. 2016; 87(3): 310-3.
- Moghazy D., Sharan C., Nair M., Rackauskas C., Burnette R., Diamond M. et al. Sertoli–Leydig cell tumor with unique nail findings in a post-menopausal woman: a case report and literature review. J. Ovarian Res. 2014; 7: 83. https://dx.doi.org/10.1186/s13048-014-0083-5.
- Inam Z.S., Azizi A.H., Holland S.W. An 88-year-old woman with flushing, alopecia and hirsutism and a Sertoli–Leydig cell tumour. BMJ Case Rep. 2018; 2018: bcr2017222589. https://dx.doi.org/10.1136/bcr-2017-222589.
- Tsuzuki Y., Kikuchi I., Nojima M., Yoshida K., Hashizume A., Tomita S. A case report: ovarian Sertoli–Leydig cell tumor with hyperestrogenism and endometrial hyperplasia in a postmenopausal woman. Jpn. Clin. Med. 2017; 8: 1179066017695239. https://dx.doi.org/10.1177/1179066017695239.
- Brandone N., Borrione C., Rome A., Maues de Paula A. Ovarian Sertoli–Leydig tumor: a tricky tumor. Ann. Pathol. 2018; 38(2): 131-6. https://dx.doi.org/10.1016/j.annpat.2018.01.002.
- Moussa D., Aziz D.A., Niassy D.A., Espérence K.C., Youssou N., Charles M.J. et al. Sertoli-Leydig cell tumor of the ovary: case study of a 22-year old woman. Pan. Afr. Med. J. 2016; 25: 36. https://dx.doi.org/10.11604/pamj.2016.25.36.10469.
- Turkyilmaz Z., Karabulut R., Ozbakir F., Pinarli G., Arda Inan M., Oguz A. et al. Recurrent Sertoli–Leydig cell tumor of ovary in 8-year-old girl. Scott. Med. J. 2016; 61(1): 56-9. https://dx.doi.org/10.1177/0036933015619297.
- Stavrakis T., Kalogiannidis I., Petousis S., Tsompanidou C., Delkos D., Prapas N. et al. Fertility-sparing management and obstetric outcomes in a 20-year-old patient with a Sertoli–Leydig cell tumor of the ovary: a case report and review of the literature. Oncol. Lett. 2016; 12(2): 1079-82. https://dx.doi.org/10.3892/ol.2016.4695.
- Liggins C.A., Ma L.T., Schlumbrecht M.P. Sertoli–Leydig cell tumor of the ovary: a diagnostic dilemma. Gynecol. Oncol. Rep. 2015; 15: 16-9. https://dx.doi.org/10.1016/j.gore.2015.12.003.
- Zhang H., Hao J., Li C.Y., Li T., Mu Y.L. Large moderately-differentiated ovarian Sertoli–Leydig cell tumor in a 13-year-old female: a case report. Oncol. Lett. 2016; 11(2): 1110-2. https://dx.doi.org/10.3892/ol.2015.3979.
- Zhang H.Y., Zhu J.E., Huang W., Zhu J. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors. Int. J. Clin. Exp. Pathol. 2014; 7(10): 6956-64.
- Rohini Dhanya C.S., Padhi S., Varghese R.G. Sertoli–Leydig cell tumor of ovary – a diagnostic dilemma. J. Clin. Diagn. Res. 2014; 8(3): 127-9. https://dx.doi.org/10.7860/JCDR/2014/7000.4099.
- Chen L., Tunnell C.D., De Petris G. Sertoli–Leydig cell tumor with heterologous element: a case report and a review of the literature. Int. J. Clin. Exp. Pathol. 2014; 7(3): 1176-81.
- Perez Lana M., Demayo S., Monastero A., Nolting M. Ovarian tumors secreting androgens: an infrequent cause of hyperandrogenism. Minerva Ginecol. 2019; 71(1): 72-7. https://dx.doi.org/10.23736/S0026-4784.18.04302-2.
- Xu Q., Zou Y., Zhang X.F. Sertoli-Leydig cell tumors of ovary: a case series. Medicine (Baltimore). 2018; 97(42): e12865. https://dx.doi.org/ 10.1097/MD.0000000000012865.
- Akman L., Ertas I.E., Gokcu M., Terek M.C., Sanci M., Sanli U.A. et al. Ovarian sertoli-leydig cell tumors: a multicenter long-term clinicopathological analysis of 27 patients. J. Cancer Res. Ther. 2016; 12(1): 290-4. https://dx.doi.org/10.4103/0973-1482.158037.
- Schneider D.T., Orbach D., Cecchetto G., Stachowicz-Stencel T., Brummel B.,Brecht I.B. et al. Ovarian Sertoli–Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT). Eur. J. Cancer. 2015; 51(4): 543-50. https://dx.doi.org/10.1016/j.ejca.2014.11.013.
- Young R.H., Scully R.E. Ovarian Sertoli cell tumors: a report of 10 cases. Int. J. Gynecol. Pathol. 1984; 2(4): 349-63. https://dx.doi.org/10.1097/00004347-198404000-00003.
- Gressel G.M., Buza N., Pal L. Ovarian Sertoli–Leydig cell tumors: a single institution experience and review of the literature. Eur. J. Gynaecol. Oncol. 2017; 38(2): 214-20.
- Oliva E., Alvarez T., Young R.H. Sertoli cell tumors of the ovary: a clinicopathological and immunohistochemical study of 54 cases. Am. J. Surg. Pathol. 2005; 29(2): 143-56. https://dx.doi.org/10.1097/01.pas.0000149692.21205.9c.
- Weng C.S., Chen M.Y., Wang T.Y., Tsai H.W., Hung Y.C., Yu K.J. et al. Sertoli–Leydig cell tumors of the ovary: a Taiwanese Gynecologic Oncology Group study. Taiwan. J. Obstet. Gynecol. 2013; 52(1): 66-70. https://dx.doi.org/10.1016/j.tjog.2012.03.001.
- Gui T., Cao D., Shen K., Yang J., Zhang Y., Yu Q. et al. A clinicopathological analysis of 40 cases of ovarian Sertoli–Leydig cell tumors. Gynecol. Oncol. 2012; 127(2): 384-9. https://dx.doi.org/10.1016/j.ygyno.2012.07.114.
- Хохлова С.В., Давыдова И.Ю., Коломиец Л.А., Кузнецов В.В., Новикова Е.Г., Трякин А.А., Тюляндина А.С., Урманчеева А.Ф. Практические рекомендации по лекарственному лечению злокачественных неэпителиальных опухолей яичников. Злокачественные опухоли. 2019; 9(3, Приложение 2): 177-91. [Hokhlova S.V, Davydova I.Yu., Kolomiets L.A., Kuznetsov V.V., Novikova E.G., Tryakin A.A., Tyulyandina A.S., Urmancheeva A.F. Practical recommendations for the drug treatment of malignant non-epithelial ovarian tumors. Malignant tumor. 2019; 9(3, Suppl. 2): 177-91. (in Russian)]. https://dx.doi.org/10.18027 / 2224-5057-2019-9-3s2-177-191.
Received 16.09.2020
Accepted 11.12.2020
About the Authors
Yulia N. Ponomareva, MD, PhD, Professor, Head of the Department of Gynecology, Moscow Clinical Scientific Center, Moscow Healthcare Department.Tel.: +7(495)304-30-35. E-mail: y.ponomareva@mknc.ru. ORCID: 0000-0001-5436-9119.
11123, Russia, Moscow, shosse Entuziastov, 86.
Ekaterina A. Loginova, MD, Research Fellow of the Department of Gynecology, Moscow Clinical Scientific Center, Moscow Healthcare Department.
Tel.: +7 (495)304-30-35; +7(985)182-28-58. E-mail: e.loginova@mknc.ru. ORCID: 0000-0002-5061-1227.
11123, Russia, Moscow, shosse Entuziastov, 86.
Inessa M. Telezhnikova, Research Fellow of the Department of Morbid Anatomy, Moscow Clinical Scientific Center, Moscow Healthcare Department.
Tel.: +7 (495)304-30-35; +7(909)956-33-39. E-mail: inessssa@inbox.ru. ORCID: 0000-0002-1491-2882.
11123, Russia, Moscow, shosse Entuziastov, 86.
For citation: Ponomareva Yu.N., Loginova E.A., Telezhnikova I.M. Virilizing ovarian tumors in postmenopause: a literature review and a rare clinical case.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021; 1: 178-185 (in Russian)
https://dx.doi.org/10.18565/aig.2021.1.178-185